The European Society of Cardiology (ESC) Working Group (WG) on Cardiovascular Pharmacotherapy works with all aspects of cardiovascular pharmacotherapy: From basic pharmacology over clinical trials to clinical pharmacotherapy. Over the last years, the WG has focused on: Polypharmacy, for example the heart failure patient treated with various drugs for the heart as well as for comorbidities. On sudden cardiac death, for example the treatment of arrhythmia as well as the prevention of pharmacologically induced arrhythmia. Moreover, on clinical trials science, for example on optimum planning and conduction of clinical trials, on optimum evaluation of results as well as on development of new types of trials.
The WG presently consists of 300 members. To apply for membership go to www.escardio.org/pharmacology. Membership is free to members of national cardiology societies within ESC. Membership is granted based on shown interest in cardiovascular pharmacotherapy documented by, for example authorship on papers, oral presentations or posters dealing with aspects of cardiovascular pharmacotherapy. Members can take part in all the WG's activities and vote for the WG board-the nucleus-consisting of 14 nucleus members.
The WG is an important contributor to ESC at most levels: † The WG Journal: European Heart Journal-Cardiovascular Pharmacotherapy. Moreover, a number of additional position papers are in preparation. † Working group trials training workshops. The WG has recently developed a workshop focusing on optimum planning and conduction of clinical trials, on optimum evaluation of results as well as on development of new types of trials. The initiative became possible due to an unrestricted grant to the WG from AstraZeneca. The workshop has hitherto taken place at congresses in Rome and in Singapore and more are planned.
Over the time to come the WG will have to give its absolutely highest priority to European Heart Journal-Cardiovascular Pharmacotherapy to ensure its rapid success. Subsequently, new projects are expected to be launched, for example Teaching Courses and an ESC Handbook/Textbook on Cardiovascular Pharmacotherapy.
